|
|
|
Volumn 13, Issue 3 Suppl, 2003, Pages
|
|
Clinical safety and efficacy of enfuvirtide (T-20), a new fusion inhibitor. A review of the presentation at the satellite symposium "New hope: advancing care in HIV infection" at the 15th annual Association of Nurses in AIDS Care conference, November 2002.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ENFUVIRTIDE;
GLYCOPROTEIN GP 41;
HUMAN IMMUNODEFICIENCY VIRUS FUSION INHIBITOR;
PEPTIDE FRAGMENT;
ADULT;
ARTICLE;
CLINICAL TRIAL;
FEMALE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MALE;
TREATMENT OUTCOME;
VIRUS LOAD;
ADULT;
CLINICAL TRIALS;
FEMALE;
HIV ENVELOPE PROTEIN GP41;
HIV FUSION INHIBITORS;
HIV INFECTIONS;
HUMANS;
MALE;
PEPTIDE FRAGMENTS;
TREATMENT OUTCOME;
VIRAL LOAD;
|
|
EID: 0038279960
PISSN: 10530894
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|
